Skip to main content
Premium Trial:

Request an Annual Quote

Bioinformatics Publishing Launches Global News Service, Newsletter

Premium

NEW YORK--Welcome to BioInform! Bioinformatics Publishing LLC is pleased to present the premier issue of a new biweekly newsletter dedicated to the practice and the business of bioinformatics. Widely identified as one of the leading disciplines of the 21st century, bioinformatics has long deserved a news service for which it is the exclusive focus. Now, BioInform will fill this critical information gap.

Each issue of BioInform will bring an exciting, lively, and informative combination of up-to-the-minute inside news; profiles of the people, companies, laboratories, and technologies that define this cutting-edge field; new products and services; and a schedule of upcoming events. In addition, the BioInform web site (http://www.bioinform.com) will soon be upgraded.

Every two weeks, the editors of BioInform will scour the globe for the most compelling stories in bioinformatics in order to bring you the news you need to optimize productivity and help your organization fulfill its mission. But the information business is a two-way street. We'd also like to hear from you about how we can make BioInform even more useful in the coming months. Drop a line to [email protected] to share your thoughts.

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.